Validation of proposed signatures on data collected at 12 month follow-up.

aThe full set of samples contained data on 50 Controls and 92 MCI Progressors.bThe size-matched groups contained data on 50 Controls and 50 MCI Progressors.cThe full set of samples contained data on 50 Controls and 97 AD patients.dThe size-matched groups contained data on 50 Controls and 50 AD patients.a. 完整样本集包含50名正常对照组（Controls）受试者与92名轻度认知障碍（Mild Cognitive Impairment, MCI）进展者的相关数据。 b. 样本量匹配组别包含50名正常对照组受试者与50名轻度认知障碍进展者的相关数据。 c. 完整样本集包含50名正常对照组受试者与97名阿尔茨海默病（Alzheimer's Disease, AD）患者的相关数据。 d. 样本量匹配组别包含50名正常对照组受试者与50名阿尔茨海默病患者的相关数据。